MNG17
—
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- —
- cancer_type_detailed
- —
- subtype
- —
GSVA pathway preview (50 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Top 10 elevated
- PROTEIN_SECRETION+0.232
- BILE_ACID_METABOLISM+0.218
- ESTROGEN_RESPONSE_LATE+0.203
- ANDROGEN_RESPONSE+0.187
- KRAS_SIGNALING_UP+0.137
- ESTROGEN_RESPONSE_EARLY+0.105
- SPERMATOGENESIS+0.090
- HEME_METABOLISM+0.072
- INFLAMMATORY_RESPONSE+0.070
- KRAS_SIGNALING_DN+0.070
Top 10 suppressed
- MYC_TARGETS_V2-0.545
- EPITHELIAL_MESENCHYMAL_TRANSITION-0.445
- WNT_BETA_CATENIN_SIGNALING-0.393
- UNFOLDED_PROTEIN_RESPONSE-0.325
- REACTIVE_OXYGEN_SPECIES_PATHWAY-0.322
- MYC_TARGETS_V1-0.317
- OXIDATIVE_PHOSPHORYLATION-0.317
- ANGIOGENESIS-0.302
- ADIPOGENESIS-0.290
- G2M_CHECKPOINT-0.264
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
8 twins match this tumor's tissue · 2 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | MNG14 | — | — | 0.802 |
| 2 | MNG26 | — | — | 0.794 |
| 3 | R347 | — | — | 0.788 |
| 4 | TCGA-55-1592-01A-01R-0946-07 | — | cohortA1 | 0.787 |
| 5 | BS_5PJCHF6V | Med | Medulloblastoma | 0.785 |
| 6 | R141 | — | — | 0.773 |
| 7 | TCGA-55-7727-01A-11R-2170-07 | — | cohortMD2 | 0.770 |
| 8 | MDT-AP-3326 | Med | Medulloblastoma | 0.769 |
| 9 | C3N-02828 | — | cohortA1 | 0.761 |
| 10 | SRR934723 | — | — | 0.759 |